Journal article
The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate)
- Abstract:
-
Bisphosphonates are widely used in the treatment of clinical disorders characterized by increased bone resorption, including osteoporosis, Paget's disease, and the skeletal complications of malignancy. The antiresorptive potency of the nitrogen-containing bisphosphonates on bone in vivo is now recognized to depend upon two key properties, namely mineral binding affinity and inhibitory activity on farnesyl pyrophosphate synthase (FPPS), and these properties vary independently of each other in ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Procter and Gamble
More from this funder
Bibliographic Details
- Publisher:
- American Society for Bone and Mineral Research Publisher's website
- Journal:
- Journal of Bone and Mineral Research Journal website
- Volume:
- 32
- Issue:
- 9
- Pages:
- 1860-1869
- Publication date:
- 2017-04-21
- Acceptance date:
- 2017-03-22
- DOI:
- EISSN:
-
1523-4681
- ISSN:
-
0884-0431
- Pmid:
-
28337806
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:687171
- UUID:
-
uuid:46b10779-0dbb-4f67-82b8-cbbf6607dce3
- Local pid:
- pubs:687171
- Source identifiers:
-
687171
- Deposit date:
- 2017-12-06
Terms of use
- Copyright holder:
- © 2017 Lawson, et al
- Copyright date:
- 2017
- Notes:
- This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record